<scp>Interleukin‐17RA</scp> blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum-Reference-Cited by-同舟云学术

Interleukin‐17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum

Published:2022-06-02 Issue:2 Volume:187 Page:223-233
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Navrazhina Kristina¹²^ORCID,Frew John W.¹^ORCID,Grand David¹^ORCID,Williams Samuel C.¹²,Hur Hong³^ORCID,Gonzalez Juana¹^ORCID,Garcet Sandra¹^ORCID,Krueger James G.¹^ORCID

Affiliation:

1. Laboratory for Investigative Dermatology The Rockefeller University New York NY USA

2. Weill Cornell/Rockefeller/Sloan Kettering Tri‐Institutional MD‐PhD program New York NY USA

3. Center for Clinical and Translational Science The Rockefeller University New York NY USA

Funder

Hidradenitis Suppurativa Foundation

National Center for Advancing Translational Sciences

National Institute of General Medical Sciences

Publisher

Oxford University Press (OUP)

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.21060

Reference65 articles.

An Update on Health-Related Quality of Life and Patient-Reported Outcomes in Hidradenitis Suppurativa

2. Psychophysical Aspects of Hidradenitis Suppurativa

3. Hidradenitis suppurativa markedly decreases quality of life and professional activity;Matusiak Ł;J Am Acad Dermatol,2010

4. Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa

5. A Systematic Review of Promising Therapeutic Targets in Hidradenitis Suppurativa: A Critical Evaluation of Mechanistic and Clinical Relevance

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatocyte Growth Factor Has Unique Functions in Keratinocytes that Differ from those of IL-17A and TNF and May Contribute to Inflammatory Pathways in Hidradenitis Suppurativa;Journal of Investigative Dermatology;2024-07

2. Efectividad y seguridad de los fármacos biológicos y las moléculas pequeñas en la hidradenitis supurativa: experiencia en un centro terciario y propuesta de un algoritmo terapéutico;Piel;2024-06

3. The use of biologics and JAK inhibitors in the management of moderate to severe Hidradenitis Suppurativa treatment: a scoping review;Archives of Dermatological Research;2024-05-25

4. Brodalumab for moderate–severe hidradenitis suppurativa: An open‐label multicentric cohort study in real clinical practice;Australasian Journal of Dermatology;2024-04-10

5. The Hidradenitis Suppurativa Omics Database (HS-OmicsDB);Journal of Investigative Dermatology;2024-01